Bank of America’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Sell |
91,612
-240,509
| -72% | -$818K | ﹤0.01% | 5039 |
|
|
2025
Q1 | $1.33M | Sell |
332,121
-12,839
| -4% | -$51.5K | ﹤0.01% | 4187 |
|
|
2024
Q4 | $2.24M | Buy |
344,960
+138,492
| +67% | +$899K | ﹤0.01% | 3673 |
|
|
2024
Q3 | $1.14M | Buy |
206,468
+4,713
| +2% | +$26.1K | ﹤0.01% | 4208 |
|
|
2024
Q2 | $1.13M | Buy |
201,755
+112,388
| +126% | +$627K | ﹤0.01% | 4116 |
|
|
2024
Q1 | $600K | Buy |
89,367
+54,362
| +155% | +$365K | ﹤0.01% | 4449 |
|
|
2023
Q4 | $319K | Sell |
35,005
-51,627
| -60% | -$471K | ﹤0.01% | 4902 |
|
|
2023
Q3 | $478K | Buy |
86,632
+18,457
| +27% | +$102K | ﹤0.01% | 4512 |
|
|
2023
Q2 | $582K | Sell |
68,175
-114,684
| -63% | -$979K | ﹤0.01% | 4386 |
|
|
2023
Q1 | $1.68M | Sell |
182,859
-369,693
| -67% | -$3.4M | ﹤0.01% | 3836 |
|
|
2022
Q4 | $5.64M | Sell |
552,552
-275,913
| -33% | -$2.82M | ﹤0.01% | 2799 |
|
|
2022
Q3 | $12.2M | Buy |
828,465
+802,466
| +3,087% | +$11.8M | ﹤0.01% | 2045 |
|
|
2022
Q2 | $279K | Sell |
25,999
-217,939
| -89% | -$2.34M | ﹤0.01% | 5125 |
|
|
2022
Q1 | $2.63M | Buy |
243,938
+238,217
| +4,164% | +$2.57M | ﹤0.01% | 3736 |
|
|
2021
Q4 | $93K | Buy |
5,721
+5,498
| +2,465% | +$89.4K | ﹤0.01% | 6081 |
|
|
2021
Q3 | $5K | Buy |
+223
| New | +$5K | ﹤0.01% | 6816 |
|